Insufficient scRNA-seq data for expression of LPAR4 at single-cell level.
Insufficient scRNA-seq data for expression of LPAR4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 88% | 40.91 | 2316 / 2642 | 80% | 3.94 | 566 / 705 |
ovary | 99% | 216.87 | 179 / 180 | 21% | 0.37 | 91 / 430 |
breast | 94% | 50.08 | 430 / 459 | 20% | 0.39 | 222 / 1118 |
uterus | 97% | 68.94 | 165 / 170 | 10% | 0.35 | 47 / 459 |
esophagus | 92% | 61.84 | 1336 / 1445 | 11% | 0.16 | 20 / 183 |
adipose | 91% | 49.30 | 1097 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 87% | 35.80 | 1156 / 1335 | 0% | 0 | 0 / 0 |
intestine | 80% | 34.91 | 769 / 966 | 5% | 0.10 | 24 / 527 |
skin | 69% | 19.50 | 1254 / 1809 | 13% | 0.87 | 59 / 472 |
thymus | 78% | 22.19 | 512 / 653 | 1% | 0.02 | 8 / 605 |
heart | 79% | 35.64 | 684 / 861 | 0% | 0 | 0 / 0 |
bladder | 76% | 21.29 | 16 / 21 | 2% | 0.05 | 11 / 504 |
prostate | 61% | 13.56 | 150 / 245 | 0% | 0.00 | 1 / 502 |
stomach | 47% | 54.62 | 170 / 359 | 12% | 0.19 | 33 / 286 |
lung | 36% | 7.80 | 206 / 578 | 6% | 0.13 | 69 / 1155 |
spleen | 27% | 5.19 | 65 / 241 | 0% | 0 | 0 / 0 |
pancreas | 15% | 2.35 | 48 / 328 | 7% | 0.09 | 13 / 178 |
kidney | 17% | 3.42 | 15 / 89 | 5% | 0.14 | 43 / 901 |
adrenal gland | 15% | 1.95 | 39 / 258 | 0% | 0.01 | 1 / 230 |
muscle | 15% | 2.73 | 124 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 6% | 1.03 | 59 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.05 | 2 / 45 |
liver | 1% | 0.22 | 2 / 226 | 0% | 0 | 0 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0035025 | Biological process | positive regulation of Rho protein signal transduction |
GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0016604 | Cellular component | nuclear body |
GO_0005886 | Cellular component | plasma membrane |
GO_0035727 | Molecular function | lysophosphatidic acid binding |
GO_0070915 | Molecular function | lysophosphatidic acid receptor activity |
Gene name | LPAR4 |
Protein name | Lysophosphatidic acid receptor 4 Lysophosphatidic acid receptor 4 (LPA receptor 4) (LPA-4) (G-protein coupled receptor 23) (P2Y purinoceptor 9) (P2Y9) (P2Y5-like receptor) (Purinergic receptor 9) |
Synonyms | GPR23 P2RY9 LPA4 |
Description | FUNCTION: Receptor for lysophosphatidic acid (LPA), a mediator of diverse cellular activities. Transduces a signal by increasing the intracellular calcium ions and by stimulating adenylyl cyclase activity. The rank order of potency for agonists of this receptor is 1-oleoyl- > 1-stearoyl- > 1-palmitoyl- > 1-myristoyl- > 1-alkyl- > 1-alkenyl-LPA. . |
Accessions | ENST00000514744.5 Q99677 ENST00000614823.5 ENST00000435339.3 V9GY74 |